Literature DB >> 21740322

Cystatin C in pre-eclampsia.

Aleksandra Novakov Mikic1, Velibor Cabarkapa, Aleksandra Nikolic, Daniela Maric, Snezana Brkic, Gorana Mitic, Marina Ristic, Zoran Stosic.   

Abstract

OBJECTIVE: To evaluate diagnostic value of cystatin C serum levels as alternative marker of renal function in pre-eclamsia (PE) and compare it with the traditional markers of renal function, creatinine and uric acid. In order to investigate the possible influence of inflammation on biochemical markers of renal function, serum levels of high sensitive CRP were measured (hsCRP).
METHODS: In this prospective study markers of kidney function were investigated in two groups of pregnant women: one with PE (n = 32) and the other of healthy pregnant women (n = 60). Serum cystatin C levels were measured as well as levels of traditional renal markers creatinin and uric acid and levels of high sensitive C-reactive protein.
RESULTS: Serum levels of cystatin C, creatinine and uric acid were significantly higher in the PE group than in the control group. Serum levels of hsCRP were higher in approximately the same number of patients with PE (50%) as in normal pregnancies (40%), without significant differences in CRP values between the two groups of patients.
CONCLUSIONS: Cystatin C serum level may have significant role as a marker of pre-eclampsia specially when used in combination with uric acid levels.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21740322     DOI: 10.3109/14767058.2011.601366

Source DB:  PubMed          Journal:  J Matern Fetal Neonatal Med        ISSN: 1476-4954


  7 in total

1.  Activity of Proteolytic Enzymes and Level of Cystatin C in the Peripartum Period.

Authors:  Anna Cyganek; Aleksandra Wyczalkowska-Tomasik; Patrycja Jarmuzek; Barbara Grzechocinska; Zoulikha Jabiry-Zieniewicz; Leszek Paczek; Miroslaw Wielgos
Journal:  Biomed Res Int       Date:  2016-01-20       Impact factor: 3.411

Review 2.  A Dormant Microbial Component in the Development of Preeclampsia.

Authors:  Douglas B Kell; Louise C Kenny
Journal:  Front Med (Lausanne)       Date:  2016-11-29

3.  Cystatin-C as a Marker for Renal Impairment in Preeclampsia.

Authors:  Apeksha Niraula; Madhab Lamsal; Nirmal Baral; Shankar Majhi; Seraj Ahmed Khan; Pritha Basnet; Kashyap Dahal
Journal:  J Biomark       Date:  2017-07-11

4.  Reference Intervals for Non-Fasting CVD Lipids and Inflammation Markers in Pregnant Indigenous Australian Women.

Authors:  Tracy L Schumacher; Christopher Oldmeadow; Don Clausen; Loretta Weatherall; Lyniece Keogh; Kirsty G Pringle; Kym M Rae
Journal:  Healthcare (Basel)       Date:  2017-10-14

5.  Cystatin C as a novel predictor of preterm labor in severe preeclampsia.

Authors:  Krittanont Wattanavaekin; Maethaphan Kitporntheranunt; Chatchai Kreepala
Journal:  Kidney Res Clin Pract       Date:  2018-12-31

6.  Renal markers in normal and hypertensive disorders of pregnancy in Indian women: a pilot study.

Authors:  Y Padma; V B Aparna; B Kalpana; V Ritika; P R Sudhakar
Journal:  Int J Reprod Contracept Obstet Gynecol       Date:  2013

7.  Predictive Performance of Serum β-hCG MoM Levels for Preeclampsia Screening: A Meta-Analysis.

Authors:  Xiao Zhang; Zhao Huangfu; Fangxin Shi; Zhen Xiao
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-10       Impact factor: 5.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.